...
首页> 外文期刊>Current Gene Therapy >Progress Towards Liver and Lung-Directed Gene Therapy with Helper- Dependent Adenoviral Vectors
【24h】

Progress Towards Liver and Lung-Directed Gene Therapy with Helper- Dependent Adenoviral Vectors

机译:辅助性腺病毒载体在肝和肺相关基因治疗方面的进展

获取原文
获取原文并翻译 | 示例
           

摘要

Helper-dependent adenoviral vectors (HDAd) have several characteristics making them very attractive for human gene therapy. These vectors are completely devoid of viral coding sequences and are able to mediate high efficiency transduction in vivo to direct high level transgene expression with negligible chronic toxicity. Progress towards liver and lung directed gene therapy with HDAd as well as the current obstacles facing human applications and possible strategies to overcome these obstacles are discussed.
机译:依赖于助手的腺病毒载体(HDAd)具有几个特征,使其对人类基因治疗非常有吸引力。这些载体完全没有病毒编码序列,并且能够介导体内高效转导以指导高水平转基因表达,而慢性毒性可忽略不计。讨论了用HDAd向肝和肺定向基因治疗的进展以及人类应用面临的当前障碍以及克服这些障碍的可能策略。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号